David B Wells bought $1.2M of Hims & Hers Health (HIMS)
Executed May 26, disclosed May 26, the same day.
Over the 21 trading sessions from the disclosed entry session (May 26), the stock returned +36.9% (delay-adjusted); from the execution session (May 26), +36.9%. Derived: entry at the session's open, exit at the close 20 sessions later.
David B Wells (Director) filed 1 Form 4 report in the trailing twelve months (1 purchase, 0 sales), most often in Hims & Hers Health, Inc. (HIMS). Across 1 priced purchase filing, the average 21-session return was +36.9% from execution and +36.9% from disclosure (delay-adjusted; derived). The largest single filing was $1.2M of HIMS (48,400 sh × $24.23, as filed), executed May 26.
Healthcare · Hims & Hers Health, Inc. operates as a consumer-first health and wellness platform that connects consumers to licensed healthcare professio…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→40,000 sh × $29.99
Exec Nov 13 2024
Filed Nov 14 2024 · 5:30 PM ET